Avanos Medical (AVNS) Current Assets (2013 - 2026)

Avanos Medical (AVNS) has 14 years of Current Assets data on file, last reported at $325.0 million in Q1 2026.

• For the quarter ending Q1 2026, Current Assets fell 7.78% year-over-year to $325.0 million; the trailing twelve-month figure through Mar 2026 stood at $325.0 million (down 7.78% YoY), and the FY2025 full-year result was $355.4 million, down 9.66% from the prior year.
• Current Assets slipped to $325.0 million in Q1 2026, from $355.4 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $624.1 million in Q4 2022 to a low of $325.0 million in Q1 2026.
• A 5-year average of $440.6 million and a median of $453.8 million in 2023 frame the typical range for Current Assets.
• Across the five-year window, Current Assets jumped 45.95% in 2022 and dropped 25.65% in 2025, its largest moves.
• Tracing AVNS's Current Assets over 5 years: stood at $624.1 million in 2022, then fell by 21.97% to $487.0 million in 2023, then fell by 19.22% to $393.4 million in 2024, then fell by 9.66% to $355.4 million in 2025, then retreated by 8.55% to $325.0 million in 2026.
• Business Quant data shows AVNS's Current Assets at $325.0 million in Q1 2026, $355.4 million in Q4 2025, and $351.4 million in Q3 2025.